Peptide receptor radionuclide therapy of neuroendocrine tumors : how important is internal dosimetry?
dc.contributor.author | Lawal, I. | en_ZA |
dc.contributor.author | Louw, L. | en_ZA |
dc.contributor.author | Warwick, James | en_ZA |
dc.contributor.author | Nyakale, N. | en_ZA |
dc.contributor.author | Steyn, R. | en_ZA |
dc.contributor.author | Lengana, T. | en_ZA |
dc.contributor.author | Ellmann, A. | en_ZA |
dc.contributor.author | Kotze, T. | en_ZA |
dc.contributor.author | Vangu, M. | en_ZA |
dc.contributor.author | Vorster, M. | en_ZA |
dc.contributor.author | Sathekge, M. | en_ZA |
dc.date.accessioned | 2021-03-10T11:20:18Z | |
dc.date.available | 2021-03-10T11:20:18Z | |
dc.date.issued | 2019 | |
dc.description | CITATION: Lawal, I., et al. 2019. Peptide receptor radionuclide therapy of neuroendocrine tumors : how important is internal dosimetry?. South African Journal of Surgery, 57(1):58-59. | |
dc.description.abstract | No abstract available | en_ZA |
dc.description.uri | http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0038-23612019000100016 | |
dc.description.version | Publishers version | |
dc.format.extent | 2 pages | |
dc.identifier.citation | Lawal, I., et al. 2019. Peptide receptor radionuclide therapy of neuroendocrine tumors : how important is internal dosimetry?. South African Journal of Surgery, 57(1):58-59 | |
dc.identifier.issn | 2078-5151 (online) | |
dc.identifier.issn | 0038-2361 (print) | |
dc.identifier.uri | http://hdl.handle.net/10019.1/109636 | |
dc.language.iso | en_ZA | en_ZA |
dc.publisher | Health and Medical Publishing Group | |
dc.rights.holder | Authors retain copyright | |
dc.subject | Peptide drugs -- Isotopes | en_ZA |
dc.subject | Radiopharmaceuticals | en_ZA |
dc.subject | Radioisotopes | en_ZA |
dc.subject | Neuroendocrine tumors -- Treatment | en_ZA |
dc.subject | Radiation dosimetry | en_ZA |
dc.title | Peptide receptor radionuclide therapy of neuroendocrine tumors : how important is internal dosimetry? | en_ZA |
dc.type | Other | en_ZA |